Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Europe midday: Medical product makers in focus on tariff threat
(Sharecast News) - European shares were lower on Thursday as investors looked ahead to key US jobs data later in the day, while medical equipment stocks were under pressure on reports the Trump administration is starting a probe into imports as a prelude to more tariffs. The pan-European Stoxx 600 index was down 0.43% to 551 at 1156 BST. Germany's DAX declined 0.67% to 23,602 and France's CAC 40 slid 0.47% to 7,804.
US shares were weaker ahead of weekly jobless claims and a final reading of second-quarter GDP scheduled for release later in the day followed by the personal consumption expenditures (PCE) price index - the Federal Reserve's preferred inflation measure - on Friday. Traders will be looking for any clues on further rate cuts this year.
Switzerland's central bank kept rates on hold at zero as it warned that Trump's tariffs had would hit the domestic economy going into 2026. The country was slapped with a shock 39% tariff rate on exports to the US at the end of July.
"The prevailing narrative for financial markets this month is that the AI boom combined with central bank support and rate cuts will sustain the equity market rally for the long term," said XTB research director Kathleen Brooks.
"Thus, the recent wobble in stocks - US stocks suffered some modest losses in recent days - has not led to a spike in volatility or fears that the sell off could deepen."
"The one risk for stocks that has yet to be priced in is a split at the Federal Reserve. In the past week, Treasury bond yields have risen, reversing weeks of declines. This is in response to some mixed commentary from Federal Reserve members."
"Interestingly, since August, Bloomberg's Fed Speak Index has been trending higher. Although the newest member, Stephen Miran, is an uber dove, other longer-term members are sounding concerned about inflation and cutting rates when the economy remains strong."
In economic news, German consumer sentiment looked was set to rise slightly heading into October, but remained in negative territory, as a more optimistic view about income prospects was offset by worries over geopolitics, jobs and inflation, a survey published on Thursday showed.
The GfK/NIMconsumer sentiment index rose to -22.3 points in October from a slightly upwardly revised -23.5 points this month.
On the equities front, medical equipment makers such as Convatec, Siemens Healthineers, Gettinge, Demant, Sonova, Philips and Carl Zeiss Meditec all fell on news the US Department of Commerce has started investigations into personal protective equipment, medical consumables, and medical equipment.
Swedish fashion retailer H&M surged on better than expected third quarter results.
Reporting by Frank Prenesti for Sharecast.com
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.